Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Annette J. Vangsted"'
Autor:
Kazimierz Groen, Fredrik H. Schjesvold, Bronno van der Holt, Mark-David Levin, Maarten R. Seefat, Markus Hansson, Maria B.L. Leys, Josien C. Regelink, Anders Waage, Damian Szatkowski, Per Axelsson, Trung Hieu Do, Asta Svirskaite, Ellen van der Spek, Einar Haukas, Dorota Knut-Bojanowska, Paula F. Ypma, Cecilie H. Blimark, Ulf-Henrik Mellqvist, Niels W.C.J. van de Donk, Pieter Sonneveld, Anja Klostergaard, Annette J. Vangsted, Niels Abildgaard, Sonja Zweegman
Publikováno v:
HemaSphere, Vol 7, Iss 9, p e940 (2023)
Externí odkaz:
https://doaj.org/article/0e36d499e0794a4290aa550a76896055
Autor:
Kari Lenita Falck Moore, Ingemar Turesson, Anna Genell, Tobias W. Klausen, Dorota Knut-Bojanowska, Louise Redder, Ingigerdur Sverrisdottir, Jonathan Thorsen, Annette J. Vangsted, Cecilie H. Blimark
Publikováno v:
Haematologica, Vol 108, Iss 6 (2022)
The prevalence of multiple myeloma (MM) is increasing in Nordic countries and the rest of the western world. Patients aged ≥75 years at diagnosis constitute an increasing proportion of all MM patients, but are underrepresented in randomized clinica
Externí odkaz:
https://doaj.org/article/b417fd552d464582913af276e4294f7d
Autor:
Paul G Richardson, María-Victoria Mateos, Annette J Vangsted, Karthik Ramasamy, Niels Abildgaard, P Joy Ho, Hang Quach, Nizar J Bahlis
Publikováno v:
Expert Review of Proteomics. 19:235-246
Insights into the mechanisms of protein homeostasis and proteasomal degradation have led to new strategies of redirecting the ubiquitin-proteasome system (UPS) to reduce or eliminate proteins or survival factors key to malignant pathobiology, multipl
Publikováno v:
Cells, Vol 9, Iss 11, p 2341 (2020)
Multiple myeloma is a malignant expansion of plasma cells and aggressively affects bone health. We show that P2X7 receptor altered myeloma growth, which affects primary bone cells in vitro. Expression on six human myeloma cell lines confirmed the het
Externí odkaz:
https://doaj.org/article/9bb106d9f734455a8a12c418423de225
Autor:
Rasmus Sørrig, Tobias W Klausen, Morten Salomo, Annette J Vangsted, Ulf Christian Frølund, Kristian T Andersen, Anja Klostergaard, Carsten Helleberg, Robert S Pedersen, Per T Pedersen, Sissel Helm-Petersen, Elena Manuela Teodorescu, Birgitte Preiss, Niels Abildgaard, Peter Gimsing, Danish Myeloma Study Group
Publikováno v:
PLoS ONE, Vol 12, Iss 12, p e0188988 (2017)
Immunoparesis (hypogammaglobulinemia) is associated to an unfavorable prognosis in newly diagnosed Multiple myeloma (MM) patients. However, this finding has not been validated in an unselected population-based cohort. We analyzed 2558 newly diagnosed
Externí odkaz:
https://doaj.org/article/90e93f8499044324a516c91c6c015912
Autor:
Annette J. Vangsted, Tobias W. Klausen, Peter Gimsing, Niels F. Andersen, Niels Abildgaard, Henrik Gregersen, Ulla Vogel
Publikováno v:
Haematologica, Vol 94, Iss 9 (2009)
Background Maintenance therapy with interferon-α after high-dose treatment with stem cell support in multiple myeloma has been intensively debated. In this study, we evaluated the response to treatment with interferon-α in relation to genetic varia
Externí odkaz:
https://doaj.org/article/e510be0ab7a34f98bf0ea7635f943cea
Autor:
Morten O, Holmström, Peter, Gimsing, Niels, Abildgaard, Niels F, Andersen, Carsten, Helleberg, Niels Aage T, Clausen, Tobias W, Klausen, Mikael, Frederiksen, Dan L, Kristensen, Herdis, Larsen, Per T, Pedersen, Kristian Thidemann, Andersen, Robert Schou, Pedersen, Bo Amdi, Jensen, Henrik, Gregersen, Annette J, Vangsted
Publikováno v:
American journal of hematology. 90(4)
Autor:
Annette J, Vangsted, Tobias W, Klausen, Niels F, Andersen, Niels, Abildgaard, Anne O, Gang, Henrik, Gregersen, Ulla, Vogel, Peter, Gimsing
Publikováno v:
European journal of haematology. 85(3)
To analyse if patients with early relapse after high-dose chemotherapy with stem cell support (HDT) benefit from new treatment strategies in a population-based setting.We conducted a retrospective study of relapse treatment and survival in 348 patien
Autor:
Thue W. Schwartz, Annette J. Vangsted
Publikováno v:
The Journal of clinical endocrinology and metabolism. 70(6)
The production and postsecretory stability of gastrin-releasing peptide (GRP) and the C-terminal part of the GRP precursor were studied in small cell lung cancer cell lines using RIAs developed against these two parts of the precursor. In three other
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.